BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Loading contract…
NP47923a Adalimumab, NP47923b Tocilizumab and NP47923c Eculizumab | UKGovscan
Loading contract…
UNKNOWNProcurement notice · The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Ref ocds-r6ebe6-0000747438
NP47923a Adalimumab, NP47923b Tocilizumab and NP47923c Eculizumab
This procurement was divided into 3 lots, each awarded separately.
Lots
3
Combined Lot Value
£94,015,132
Lot
Value
Status
Lot 3
NP47923c Eculizumab
720 days (≈2 yrs)
£10,596,600
active
Lot 2
NP47923b Tocilizumab
360 days
£35,297,308
active
Lot 1
NP47923a Adalimumab
720 days (≈2 yrs)
£48,121,224
active
Award criteria
Weightings from the notice, applied to every lot.
API Sources5%
Price95%
Key Dates
Published
20 October 2023
Tender Open
-
Tender Deadline
21 November 2023
Award Date
-
Contract Start
-
Contract End
-
Extension option
This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Procurement Details
Method
Open — any supplier may bid
Method Details
Open procedure
Route to market
Framework set up
Main category
Goods
Category
–
Delivery location
UKM
Open under
WTO Government Procurement Agreement
Buyer Reference
ocds-r6ebe6-0000747438
Legal Basis
Public Contracts Regulations 2015 (EU Directive 2014/24)